Table 3 BP data of PD patients who were suffering from the http://www.selleckchem.com/products/Abiraterone.html diseases for less than 10 years or for 10 years or longer Table 4 BP data of PD patients who had a Hoehn–Yahr scale (H-Y) of 2–3 or 4–5 During the examination, no patient developed syncope, dizziness, or any other symptoms related to the BP change. Prescribed drugs for the patients with PD were l-DOPA, dopamine agonists, selegiline, entacapon, zonisamide, and/or L-threo-DOPS. No patient received fludrocortisone. The relationships especially between the BP and the respective drugs prescribed for Inhibitors,research,lifescience,medical PD,

however, were not clear due to the small number of the examined patients and occurrence of unpredictable BP fluctuation. Discussion As conventionally known, the PD patients exhibited a tendency to develop orthostatic hypotension (Gross et al. 1972; Goldstein et al. 2005; Ziemssen and Reichmann 2010; Sharabi and Goldstein 2011), postprandial hypotension (Ejaz et al. 2006; Luciano et al. 2010), and nocturnal hypertension Inhibitors,research,lifescience,medical (Ejaz et al. Inhibitors,research,lifescience,medical 2006; Ziemssen and Reichmann 2010; Sharabi and Goldstein 2011; Sommer et al. 2011). Although orthostatic hypotension may be a risk factor leading to dizziness, syncope, and falling, many patients are known to be asymptomatic (Stuebner et al. 2013). Importantly, in the present study, the PD patients were found

to experience considerable intraday BP fluctuation, and there were observed many cases where the fluctuation was larger than 100 mmHg in terms of the difference between the highest and the lowest systolic blood pressures. Furthermore, although the average BP of the PD patients Inhibitors,research,lifescience,medical was not significantly different from that of the control patients, the highest systolic BP during the monitoring was higher in the PD patients than in the OD patients and the lowest

systolic BP was lower Inhibitors,research,lifescience,medical in the PD patients than in the OD patients, suggesting that the PD patients experience greater BP fluctuations. Such larger BP fluctuations may confuse attending medical personnel who happen to notice a high or low abnormal BP in patients. In addition, it is intriguing that some of the patients Entinostat in the advanced stage lying in bed all day long also showed large BP fluctuations, suggesting that the cardiovascular autonomic function is severely impaired and BP regulation is lost in these patients. In the treatment of PD, conventionally, occurrence of low BP has been regarded as a problem (Ziemssen and Reichmann 2010; Jain 2011; Sharabi and Goldstein 2011); however, the present study found that the PD patients frequently experience a high BP of 200 mmHg or higher, which indicates that they may potentially be subjected to risks of high BP several times a day.